Ups and Downs in the Struggle for Fair Drug Pricing (Video)
June 2, 2016
On behalf of IFARA, Lynda Dee, AIDS Treatment Activist Coalition co-founder and Fair Pricing Coalition (FPC) co-chair, spoke with FPC members Jeff Berry, Murray Penner and David Evans about the struggle for affordable medication pricing during the last year. Most notably, the newer hepatitis C drugs have been priced significantly below the high prices of earlier drugs in that class. Similarly, the first product based on the new version of tenofovir, TAF, will be sold at price parity with the older medication. And the steep jump in the price of a toxoplasmosis drug has helped galvanize the public debate around drug pricing. This affords activists an opportunity to talk about potential government involvement in this aspect of the pharmaceutical industry.
Watch the video to learn more:
The video above has been posted on TheBodyPRO.com with permission from our partners at the International Foundation for Alternative Research in AIDS (IFARA). Visit IFARA's website or YouTube channel to watch more video interviews from the CROI 2016 conference, as well as earlier meetings.
Barbara Jungwirth is a freelance writer and translator based in New York.
Follow Barbara on Twitter: @reliabletran.
Copyright © 2016 Remedy Health Media, LLC. All rights reserved.
This article was provided by TheBodyPRO. It is a part of the publication The 23rd Conference on Retroviruses and Opportunistic Infections.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.